STAT+: Pharmalittle: We’re reading about Sanofi settling an EU antitrust probe, ‘pharma bro’ Shkreli, and more

European Union antitrust regulators have accepted concessions from French pharmaceutical company Sanofi, allowing the firm to avoid financial penalties and settle an ongoing investigation. The probe centered on allegations that Sanofi conducted a misleading campaign designed to disparage a rival company's flu vaccine, which was the only competing product recommended for vulnerable patients at risk of developing the illness.

In addition to the regulatory settlement involving Sanofi, industry publications also highlighted other notable developments in the pharmaceutical sector, including legal and regulatory news concerning Martin Shkreli.